Literature DB >> 17530262

[Ocular toxoplasmosis].

U Pleyer1, N Torun, O Liesenfeld.   

Abstract

Toxoplasmosis is a parasitic zoonosis which occurs worldwide and is an important cause of blindness. The infection is naturally acquired by the ingestion of oocysts excreted by infected cats or by ingestion of tissue cysts in undercooked or raw meat. Primary infection during pregnancy may result in a congenital infection. Toxoplasmic retinochoroiditis is the most common cause of posterior uveitis in immunocompetent patients. Depending on the patient's age, ocular symptoms vary presenting with reduced visual acuity, strabismus, and nystagmus in young children - in adults decreased vision and floaters are most frequently reported. Active toxoplasmic retinochoroiditis typically presents as grey-white retinal necrosis with choroiditis, vasculitis and vitritis. However, atypical presentations including neuroretinitis, papillitis, Fuchs-like anterior uveitis, scleritis and acute retinal necrosis have been described. The diagnosis is based on clinical findings and can be supported by the detection of antibodies and Toxoplasma gondii DNA. Toxoplasmosis therapy includes antimicrobial drugs and corticosteroids. There are several regimens with different drug combinations including, among others, pyrimethamine, sulfadiazine, clindamycin, and trimethoprim-sulfamethoxazol. The prognosis for ocular toxoplasmosis is favorable in immunocompetent individuals, as long as the central macula is not directly involved. The present article reviews the epidemiology, pathogenesis, clinical presentation and management of toxoplasmic retinochoroiditis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530262     DOI: 10.1007/s00347-007-1535-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.174


  74 in total

1.  Strain typing of Toxoplasma gondii: comparison of antigen-coding and housekeeping genes.

Authors:  T Lehmann; C R Blackston; S F Parmley; J S Remington; J P Dubey
Journal:  J Parasitol       Date:  2000-10       Impact factor: 1.276

2.  OCULAR TOXOPLASMOSIS.

Authors:  M J HOGAN; S J KIMURA; G R O'CONNOR
Journal:  Arch Ophthalmol       Date:  1964-11

3.  Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications.

Authors:  R E Gilbert; D T Dunn; S Lightman; P I Murray; C E Pavesio; P D Gormley; J Masters; S P Parker; M R Stanford
Journal:  Epidemiol Infect       Date:  1999-10       Impact factor: 2.451

4.  The relationship between ocular toxoplasmosis and levels of specific toxoplasma antibodies.

Authors:  D J Chapman; D Ashburn; S A Ogston; D O Ho-Yen
Journal:  Epidemiol Infect       Date:  1999-04       Impact factor: 2.451

5.  Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis.

Authors:  M J Ronday; J V Ongkosuwito; A Rothova; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1999-03       Impact factor: 5.258

6.  Aetiology of uveitis in Sierra Leone, west Africa.

Authors:  M J Ronday; J S Stilma; R F Barbe; W J McElroy; L Luyendijk; A H Kolk; M Bakker; A Kijlstra; A Rothova
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

7.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings.

Authors:  Daniel Ajzenberg; Nadine Cogné; Luc Paris; Marie-Hélène Bessières; Philippe Thulliez; Denis Filisetti; Hervé Pelloux; Pierre Marty; Marie-Laure Dardé
Journal:  J Infect Dis       Date:  2002-08-05       Impact factor: 5.226

9.  Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E. acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I. (T.) gondii.

Authors:  A W Cornelissen; J P Overdulve; M van der Ploeg
Journal:  Parasitology       Date:  1984-06       Impact factor: 3.234

View more
  12 in total

1.  Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

Authors:  Sibylle Winterhalter; Katja Severing; Johannes Stammen; Anna Karina Maier; Erhard Godehardt; Antonia Maria Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  Ocular toxoplasmosis in Iran: 40 cases analysis.

Authors:  Seidali Tabatabaei; Mohammad Soleimani; Alireza Foroutan; Mehdinili Ahmadabadi; Reza Zarei; Nilofar Piri; Arzhang Gordiz
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

3.  The role of serology in active ocular toxoplasmosis.

Authors:  Marina Papadia; Raffaella Aldigeri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-01-11       Impact factor: 2.031

Review 4.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].

Authors:  N Torun; Z Sherif; J Garweg; U Pleyer
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

6.  Association Between Toxoplasma gondii Exposure and Heart Disease: A Case-Control Study.

Authors:  Cosme Alvarado-Esquivel; Misael Salcedo-Jaquez; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Elizabeth Rabago-Sanchez; Isabel Beristain-Garcia; Oliver Liesenfeld; Sergio Estrada-Martinez; Alma Rosa Perez-Alamos; Ediyair Alvarado-Soto
Journal:  J Clin Med Res       Date:  2016-03-20

7.  Experimental Models of Ocular Infection with Toxoplasma Gondii.

Authors:  Agata Dukaczewska; Roberto Tedesco; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-12-04

8.  Apoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept study.

Authors:  Ayu Dewi Ni Nyoman; Carsten G K Lüder
Journal:  Apoptosis       Date:  2013-06       Impact factor: 4.677

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study.

Authors:  Ashraf Bor'i; Ashraf Mahrous; Mahmoud A Al-Aswad; Haitham Y Al-Nashar; Waled M Nada; Mostafa Wagih; Ahmed M B Awad; Wael M El-Haig
Journal:  J Ophthalmol       Date:  2018-02-12       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.